SpringWorks Therapeutics’ Trial Collaboration with Allogene Therapeutics

Ambrogio Visconti

Goodwin Procter LLP advised SpringWorks Therapeutics (Nasdaq: SWTX) on its clinical trial collaboration agreement with Allogene Therapeutics, Inc. (Nasdaq: ALLO). The agreement will evaluate ALLO-715, Allogene’s…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

…

This content is for Standard 1 Year members only.
Login Join Now